CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Missing Link: Why Do Insulin-producing Cells in Type 2 Diabetes Fail to Divide?

Read More
All Posts

Type 2 diabetes is a growing epidemic, and is recognized as one of the most serious metabolic diseases worldwide. A multifactorial disease, type 2 diabetes is a perfect example of metabolic miscommunication between different organs resulting in a pathological outcome. According to CDC in the United States, 29.1 million people in the United States have diabetes, and 8.1 million may be undiagnosed. The disease affects more than 1 in every 10 adults, and seniors aged 65 and above are most affected. What makes the disease morbid are the secondary complications associated with it-- atherosclerosis and cardiomyopathy are the leading causes of death in people diagnosed with type 2 diabetes. The need for an effective treatment has become a global health priority.

Insulin Receptor Signaling in Diabetes

Glucose stimulation promotes β-cell proliferation and survival by modulating growth factor signaling pathways (Insulin/IGF-1). However, downregulation of one or more proteins of the Insulin/IGF-1 pathway results in reduced β cell mass, ultimately leading to defects in insulin secretion. Impaired insulin secretion and β-cell dysfunction are characteristic features in the pathogenesis and progression of Type 2 diabetes and result in chronic hyperglycemia. Thus, increasing β-cell proliferation to generate functional insulin-secreting cells can be a promising approach to treating Type 2 diabetes.

Islet β Cells and β-Cell Proliferation

The islet β cell is among the most differentiated mammalian cell types, with the adult β cell being largely inactive. To date, researchers studying β-cell proliferation have generally focused on mechanisms that kick off the cell cycle to try and coax inactive β cells into active cell division. Unfortunately, many of the β cells that re-enter the cell cycle do not complete it due to faulty regulatory signals.

Why Do Insulin-producing Cells in Type 2 Diabetes Fail to Divide

Confocal immunofluorescent analysis of mitotic HeLa cells during metaphase (left) or anaphase (right) using INCENP (P240) Antibod #2807 (green) and β-Tubulin (9F3) Rabbit mAb (Alexa Fluor® 555 Conjugate) #2116 (red). Blue pseudocolor = DRAQ5™ (fluorescent DNA dye).

Investigators at Joslin Diabetes Center sought to understand the failure of β cells to divide. Using β cells modified to lack Insulin/IGF-1 receptor, they previously demonstrated that these cells do not divide as efficiently as normal β cells. To determine what underlies the inability of these β cells to divide, the authors attempted to explore the link between growth factor signaling pathways and the mitotic checkpoint in β cells.

In their research article published in Cell Metabolism, the researchers studied two cell cycle proteins, namely centromere protein A (CENP-1) and polo-like kinase-1 (PLK-1), essential players in chromosomal segregation. The authors reported that β cells lacking insulin receptor had significantly reduced expression of CENP-1 and PLK-1 compared to normal β cells. Further, mice lacking CENP-1 exhibited a higher propensity to develop insulin resistance when exposed to physiological states demanding adaptive β cell compensation, such as aging, high-fat diet, and pregnancy. The number of mitotic β cells was also attenuated. Human β cells from diabetic donors were also found to have lower levels of CENP-1 and PLK-1 proteins compared to cells from healthy donors. On the other hand, mice with islet hyperplasia had increased expression of CENP-1 and PLK-1.

58982_IF CENP-F recombinant monoclonal antibody

Immunofluorescent analysis of HT-29 cells at various stages of mitosis using CENP-F (D6X4L) Rabbit mAb #58982 (green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).

 

To gain a deeper understanding of growth factor-mediated mechanisms underpinning β cell proliferation, the researchers investigated a pathway involving the transcription factor FOXM1. FOXM1 regulates the transcription of genes that drive cell proliferation. The authors discovered that insulin signaling was critical in FOXM1-mediated regulation of PLK-1 and CENP-1 in both mouse and human β cells. However, β cells with disrupted insulin signaling demonstrated loss of FOXM1 binding, leading to β cell apoptosis. This phenomenon was specific to the β cells.

These findings provide novel insights into the role of Insulin/IGF-1 signaling in cell cycle regulation, with implications for β cell loss being secondary to aberrant cell cycle regulation in Type 2 diabetes. The Insulin/IGF-1->FOXM1->PLK1->CENP-1 axis thus serves as an important pathway in β cell adaptation to delay and/or prevent progression to Type 2 diabetes. Understanding the nature of failure of physiologic and metabolic processes leading to insufficient insulin release and subsequent diabetes is essential for the development of novel anti-diabetic therapeutics.

 
References
  • Shirakawa J, Fernandez M, Takatani T, et al. Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation. Cell Metab. 2017;25(4):868-882.e5. doi:10.1016/j.cmet.2017.02.004
Cell Signaling Technology
Cell Signaling Technology
Cell Signaling Technology (CST) is a different kind of life science company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor. CST is a company of caring people driven by a devotion to facilitating good science—a company committed to doing the right thing for our customers, our communities, and our planet.

Recent Posts

Top 10 Biomarkers Powering Parkinson’s Disease Research

Parkinson’s disease (PD) is a relentless, progressive neurodegenerative disease characterized by the aggr...
Richard Cho, PhD Jun 25, 2025

Mechanisms of Cell Death: Apoptosis

What is apoptosis? Apoptosis is a form of programmed cell death (PCD) characterized by cell shrinkage, ch...
Gary Kasof, PhD Jun 18, 2025

Mapping RNA-Protein Interactions with RBP-eCLIP: Powering Discovery in RNA Biology

Guest author Dr Vince Harjono is an Application Scientist Manager at Eclipsebio. CST and Eclipsebio have ...